Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10

被引：0
|
作者：
Matthew Capehorn
Yasmin Ghani
Charlotte Hindsberger
Pierre Johansen
Esteban Jódar
机构：
[1] Rotherham Institute for Obesity (RIO),
[2] Clifton Medical Centre,undefined
[3] Novo Nordisk A/S,undefined
[4] S-cubed APS (contracted by Novo Nordisk A/S),undefined
[5] Novo Nordisk A/S,undefined
[6] Hospital Universitario Quiron Salud Madrid,undefined
[7] Universidad Europea de Madrid,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Diabetes care; GLP-1RA; Metformin; Oral antidiabetic agents; Randomised controlled trials; Semaglutide; Sulphonylurea; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1061 / 1075
页数：14
相关论文
共 50 条
  • [21] Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
    Kristin Cecilie Carlsson Petri
    Steen Hvass Ingwersen
    Anne Flint
    Jeppe Zacho
    Rune Viig Overgaard
    Diabetes Therapy, 2018, 9 : 1533 - 1547
  • [22] Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
    Hunt, Barnaby
    Malkin, Samuel J. P.
    Moes, Robert G. J.
    Huisman, Eline L.
    Vandebrouck, Tom
    Wolffenbuttel, Bruce H. R.
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [23] Greater Reductions in HbA1c and Body Weight with Once-Weekly Semaglutide vs. Comparators across Baseline BMI Subgroups: A Post Hoc Analysis of SUSTAIN 1-5 and 7-10
    Aroda, Vanita R.
    Frenkel, Ofir
    Frias, Juan P.
    Hindsberger, Charlotte
    Gylvin, Silas H.
    Le Roux, Carel
    Madsbad, Sten
    DIABETES, 2020, 69
  • [24] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
  • [25] In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly ER exenatide
    Bekiari, Eleni
    Karagiannis, Thomas
    Tsapas, Apostolos
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (08) : JC46 - JC46
  • [26] In uncontrolled type 2 diabetes, adjunctive semaglutide reduced HbA1c and body weight vs sitagliptin
    Lipscombe, Lorraine L.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (04) : JC16 - JC16
  • [27] Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes
    Overgaard, V. Rune
    Hertz, L. Christin
    Ingwersen, H. Steen
    Navarria, Andrea
    Drucker, J. Daniel
    CELL REPORTS MEDICINE, 2021, 2 (09)
  • [28] Continued Weight Loss with Semaglutide Once-Weekly in Patients without Type 2 Diabetes and Postbariatric Treatment Failure
    Lautenbach, Anne
    Wagner, Jonas
    Stoll, Fabian D.
    Aberle, Jens
    DIABETES, 2023, 72
  • [29] COST UTILITY ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE FOR PATIENTS WITH TYPE 2 DIABETES IN SAUDI ARABIA
    Hassan, M.
    Barham, L.
    VALUE IN HEALTH, 2023, 26 (12) : S54 - S54
  • [30] COST-EFFECTIVENESS ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN MEXICO
    Valdez-Huerta, R.
    Moreno, D.
    Hernandez, Paladio J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S429 - S429
12345